Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DXCM NASDAQ:PODD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDXCMDexCom$88.99+2.6%$84.58$57.52▼$93.25$34.01B1.442.73 million shs3.07 million shsPODDInsulet$290.22+1.3%$305.68$173.00▼$329.33$20.17B1.35578,892 shs528,135 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDXCMDexCom+2.59%+6.08%+5.09%+24.18%-20.50%PODDInsulet+1.27%+2.11%-5.23%+11.32%+49.31%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDXCMDexCom4.7217 of 5 stars3.53.00.04.72.72.51.9PODDInsulet4.6056 of 5 stars3.43.00.04.93.00.81.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDXCMDexCom 2.90Moderate Buy$98.7210.94% UpsidePODDInsulet 2.83Moderate Buy$321.0010.61% UpsideCurrent Analyst Ratings BreakdownLatest PODD and DXCM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/16/2025DXCMDexComMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$95.00 ➝ $100.007/15/2025DXCMDexComMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$82.00 ➝ $89.007/8/2025PODDInsuletCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy6/16/2025DXCMDexComTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$102.006/16/2025PODDInsuletTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$365.005/30/2025DXCMDexComThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$104.005/30/2025PODDInsuletThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$380.005/27/2025PODDInsuletRaymond James FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$328.00 ➝ $360.005/22/2025DXCMDexComCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$82.00 ➝ $102.005/22/2025PODDInsuletCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$320.00 ➝ $380.005/16/2025PODDInsuletSanford C. BernsteinSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform(Data available from 7/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDXCMDexCom$4.03B8.65$2.31 per share38.59$5.38 per share16.54PODDInsulet$2.20B9.29$4.49 per share64.60$17.27 per share16.80Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDXCMDexCom$576.20M$1.3466.4136.171.8512.90%30.05%10.00%7/30/2025 (Estimated)PODDInsulet$418.30M$5.5652.2058.392.5618.29%22.25%8.29%8/7/2025 (Confirmed)Latest PODD and DXCM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025PODDInsulet$0.9290N/AN/AN/A$612.31 millionN/A7/30/2025Q2 2025DXCMDexCom$0.45N/AN/AN/A$1.13 billionN/A5/8/2025Q1 2025PODDInsulet$0.81$1.02+$0.21$0.50$543.20 million$569.00 million5/1/2025Q1 2025DXCMDexCom$0.33$0.32-$0.01$0.27$1.02 billion$1.04 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDXCMDexComN/AN/AN/AN/AN/APODDInsuletN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDXCMDexCom0.551.501.32PODDInsulet1.214.473.63Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDXCMDexCom97.75%PODDInsuletN/AInsider OwnershipCompanyInsider OwnershipDXCMDexCom0.32%PODDInsulet0.39%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDXCMDexCom10,300392.11 million390.85 millionOptionablePODDInsulet3,90070.38 million70.10 millionOptionablePODD and DXCM HeadlinesRecent News About These CompaniesInsulet Corporation (NASDAQ:PODD) Position Trimmed by Knights of Columbus Asset Advisors LLC4 hours ago | marketbeat.comInsulet Corporation (NASDAQ:PODD) Stock Position Decreased by Baillie Gifford & Co.5 hours ago | marketbeat.comLongbow Finance SA Acquires New Position in Insulet Corporation (NASDAQ:PODD)5 hours ago | marketbeat.comVictory Capital Management Inc. Decreases Stake in Insulet Corporation (NASDAQ:PODD)July 25 at 3:53 AM | marketbeat.comWhat to Expect From Insulet's Q2 2025 Earnings ReportJuly 24 at 1:14 PM | msn.comWakefield Asset Management LLLP Acquires Shares of 970 Insulet Corporation (NASDAQ:PODD)July 24 at 6:24 AM | marketbeat.comAllianz Asset Management GmbH Purchases 25,095 Shares of Insulet Corporation (NASDAQ:PODD)July 24 at 4:31 AM | marketbeat.comInsulet Corp. stock underperforms Tuesday when compared to competitors despite daily gainsJuly 23 at 10:39 PM | marketwatch.comBeacon Investment Advisory Services Inc. Has $32.01 Million Position in Insulet Corporation (NASDAQ:PODD)July 22, 2025 | marketbeat.comLos Angeles Capital Management LLC Purchases 21,501 Shares of Insulet Corporation (NASDAQ:PODD)July 22, 2025 | marketbeat.comTeachers Retirement System of The State of Kentucky Sells 1,352 Shares of Insulet Corporation (NASDAQ:PODD)July 21, 2025 | marketbeat.comSargent Investment Group LLC Boosts Position in Insulet Corporation (NASDAQ:PODD)July 20, 2025 | marketbeat.comAustralianSuper Pty Ltd Purchases Shares of 34,921 Insulet Corporation (NASDAQ:PODD)July 20, 2025 | marketbeat.comForum Financial Management LP Takes Position in Insulet Corporation (NASDAQ:PODD)July 20, 2025 | marketbeat.comWealthfront Advisers LLC Sells 917 Shares of Insulet Corporation (NASDAQ:PODD)July 20, 2025 | marketbeat.comInsulet Corporation (NASDAQ:PODD) Stock Position Lifted by Cerity Partners LLCJuly 20, 2025 | marketbeat.comJennison Associates LLC Acquires 83,375 Shares of Insulet Corporation (NASDAQ:PODD)July 19, 2025 | marketbeat.comC WorldWide Group Holding A S Sells 36,000 Shares of Insulet Corporation (NASDAQ:PODD)July 18, 2025 | marketbeat.comInsulet Corporation (NASDAQ:PODD) Shares Sold by New York State Common Retirement FundJuly 18, 2025 | marketbeat.comShould You Be Adding Insulet (NASDAQ:PODD) To Your Watchlist Today?July 17, 2025 | finance.yahoo.comLeerink Partnrs Brokers Lower Earnings Estimates for InsuletJuly 17, 2025 | americanbankingnews.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePODD and DXCM Company DescriptionsDexCom NASDAQ:DXCM$88.99 +2.25 (+2.59%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$88.70 -0.30 (-0.33%) As of 07/25/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.Insulet NASDAQ:PODD$290.22 +3.64 (+1.27%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$290.33 +0.11 (+0.04%) As of 07/25/2025 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Intel's Turnaround Gains Credibility With Strong Q2 Report Qualcomm's Next Gear: A Growth Story Wall Street Might Be Missing Krispy Kreme: A Meme Stock Sugar Rush or a Sustainable Treat? From Zero to Hero? Why GoPro's Rally Could Be More Than It Seems CrowdStrike Scores Big With Gartner, But Valuation Is Stretched ServiceNow: The 2nd Wave of AI Spending Is Here Tractor Supply Revs Up on Forecast Hike and Bullish Signals A Smokin’ Hot Entry Point for Chipotle Stock Opens in Q3 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
